Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of the Touro College & University System, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to Scholarly Communications Librarian Carrie Levinson.

Total number of publications: 7,320

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

  • Argo, T., Carnahan, R., Barnett, M. J., Holman, T., & Perry, P. J. (2011). Diabetes prevalence estimates in schizophrenia and risk factor assessment. Annals of Clinical Psychiatry, 23(2), 117-124.

  • Armbruster, J., & Theiss-Abendroth, P. (2016). Deconstructing the myth of Pasewalk: Why Adolf Hitler's psychiatric treatment at the end of World War I bears no relevance. Archives of Clinical Psychiatry, 43(3), 56-9. This material can be found here.

  • Atalayer, D., Gibson, C., Konapacka, A., & Geliebter, A. (2013). Ghrelin and eating disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 40, 70-82. doi:10.1016/j.pnpbp.2012.08.011

  • Barnett, M. J., VonMuenster, S. J., Wehring, H. J., Walker, V., & Perry, P. J. (2010). Assessment of monitoring for glucose and lipid dysregulation in adult Medi-Cal patients newly started on antipsychotics. Annals of Clinical Psychiatry, 22(1), 9-18. This material can be found here.

  • Childress, A., Belchenko, D., & Lempa, B. (2017). The use of modified-release methylphenidate in the treatment of attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics, 17(2), 113-121. doi:10.1080/14737175.2016.1271714

  • Chou, T. I., & Perry, P. J. (2011). Pharmacotherapy of bipolar depression. California Pharmacist Journal, 58(4), 24-27.

  • Choy, M. (2008). New easier-to-swallow capsule approved to treat bipolar disorder. Drug Topics. This material can be found here.

  • Doroudgar, S., & Chou, T. I. (2014). How to modify psychotropic therapy for patients who have liver dysfunction. Current Psychiatry, 13(12), 46-49. This material can be found here.

  • Doroudgar, S., Chou, T., Yu, J., & Perry, P. J. (2013). Evaluation of trazodone and quetiapine for insomnia: An observational study in psychiatric inpatients. Primary Care Companion for CNS Disorders, 15(6). This material can be found here.

  • English, B. A., Thomas, K. L., Johnstone, J., Bazih, A., Gertsik, L., & Ereshefsky, L. (2014). Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia. Biomarkers in Medicine, 8(1), 29-49. doi:10.2217/bmm.13.135

  • Fish, N. (2011). Nachas ruach: Torah-based psychotherapy and tools for growth and healing. Brooklyn, NY: Targum Press.

  • Haymes, L. K. (2013). [Review of the book The PRT pocket guide: Pivotal response treatment for autism spectrum disorders, by R. Koegel & L. Koegel]. Research and Practice for Persons with Severe Disabilities, 38(1), 63-64.

  • Hopf, F. W., Simms, J. A., Chang, S. J., Seif, T., Bartlett, S. E., & Bonci, A. (2011). Chlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats. Biological Psychiatry, 69(7), 618-24.

  • Katz, M. B. (2011). A rabbi, a priest, and a psychoanalyst: Religion in the early psychoanalytic case history. Contemporary Jewry, 31(1), 3-24. doi:10.1007/s12397-010-9059-y

  • Kuperman, S., Calarge, C., Kolar, A., Holman, T., Barnett, M. J., & Perry, P. J. (2011). An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder. Annals of Clinical Psychiatry, 23(4), 270-276.

  • Perry, P. J., & Wilborn, C. A. (2012). Serotonin syndrome vs. neuroleptic malignant syndrome: A contrast of causes, diagnoses, and management. Annals of Clinical Psychiatry, 24(2), 155-162. This material can be found here.

  • Thomas, K. L., Jiang, Y., & McCombs, J. S. (2015). Clozapine revisited: Impact of clozapine vs olanzapine on health care use by schizophrenia patients on Medicaid. Annals of Clinical Psychiatry, 27(1), e1-e10. This material can be found here.

  • Thomas, K. L., La, A. Q., Punia, S., Doroudgar, S., & Perry, P. J. (2016). Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients. Annals of Clinical Psychiatry, 28(1), 37-42. This material can be found here.